Singapore markets closed

Bora Pharmaceuticals Co., LTD. (6472.TW)

Taiwan - Taiwan Delayed price. Currency in TWD
Add to watchlist
737.00-8.00 (-1.07%)
At close: 01:30PM CST
Currency in TWD

Valuation measures4

Market cap (intra-day) 75.00B
Enterprise value 75.65B
Trailing P/E 29.26
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.47
Price/book (mrq)8.81
Enterprise value/revenue 6.29
Enterprise value/EBITDA 17.45

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 320.16%
S&P500 52-week change 326.94%
52-week high 3845.00
52-week low 3612.00
50-day moving average 3723.48
200-day moving average 3686.38

Share statistics

Avg vol (3-month) 32.55M
Avg vol (10-day) 32.75M
Shares outstanding 5100.67M
Implied shares outstanding 6102.83M
Float 856.68M
% held by insiders 143.04%
% held by institutions 18.94%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 46.16
Forward annual dividend yield 40.77%
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 41.19
Payout ratio 423.68%
Dividend date 3N/A
Ex-dividend date 406 Jul 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 21.34%
Operating margin (ttm)35.43%

Management effectiveness

Return on assets (ttm)13.72%
Return on equity (ttm)36.34%

Income statement

Revenue (ttm)14.2B
Revenue per share (ttm)141.52
Quarterly revenue growth (yoy)-39.50%
Gross profit (ttm)N/A
EBITDA 5.73B
Net income avi to common (ttm)3.03B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)40.00%

Balance sheet

Total cash (mrq)3.4B
Total cash per share (mrq)33.58
Total debt (mrq)4.99B
Total debt/equity (mrq)42.42%
Current ratio (mrq)1.29
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)4.61B
Levered free cash flow (ttm)3.15B